Results 241 to 250 of about 2,675,396 (301)

The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug Monitoring. [PDF]

Crohns Colitis 360
Gilmore R, Fernandes R, Schildkraut T, Joshi R, Lin L, Vorgin S, Etchegaray A, Shanmuga Anandan A, Tambakis G, Loebenstein M, An YK, Begun J, Wright EK.   +12 more
europepmc   +1 more source

Comparative Real-World Effectiveness of Anti-TNF, Ustekinumab and Vedolizumab in Crohn's Disease Over 24 Months: A Pooled Analysis From the Prospective UMBRELLA-IBD Registry in Germany. [PDF]

Aliment Pharmacol Ther
Bokemeyer A, Tran F, Plachta-Danielzik S, Gilman E, Wenske T, Gaskins M, Schreiber S, Bokemeyer B.   +7 more
europepmc   +1 more source

Real-world treatment courses after anti-TNF de-escalation in older adults with rheumatoid arthritis: a medicare cohort study. [PDF]

BMC Rheumatol
Lee J, Martindale J, Makris UE, Bynum JPW.   +3 more
europepmc   +1 more source

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.

JAMA Dermatol
Kimball AB, Sawicki KT, Ackerman L, Lima H, Giamarellos-Bourboulis EJ, Zhan T, Drogaris L, Gu Y, Lee CM, Akbari M, Williams DA, Bechara FG.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Anti-TNF

Revista Paulista de Reumatologia, 2021
O fator de necrose tumoral (TNF), descrito inicialmente na década de 1970, é um dos alvos de atuação molecular que mais atraiu a atenção nas últimas décadas. Durante a década de 1980, foi demonstrado o papel do TNF na etiopatogenia das doenças inflamatórias e estudos iniciais demonstraram uma concentração elevada dessa citocina no líquido sinovial e no
openaire   +2 more sources

Anti-TNF therapy

Best Practice and Research in Clinical Rheumatology, 2011
There are now five anti-tumour necrosis factor (TNF) drugs licenced for use in rheumatoid arthritis. This chapter examines the similarities and differences between the drugs and looks for clues with regard to their rational prescribing. The major difference is between the monoclonal antibody-based drugs and the soluble receptor etanercept.
John D Isaacs
exaly   +4 more sources

Anti‐TNF and Sex Hormones

Annals of the New York Academy of Sciences, 2006
Abstract:  Whenever serum estrogen concentrations are normal in rheumatoid arthritis (RA) patients, lower androgen concentrations (i.e., testosterone, androstenedione, and dehydroepiandrosterone sulfate [DHEAS]) are detected in the serum as well as in the synovial fluid of male and female RA patients.
CUTOLO, MAURIZIO, SULLI, ALBERTO, CAPELLINO S, VILLAGGIO, BARBARA, MONTAGNA, PAOLA, PIZZORNI, CARMEN, PAOLINO S, SERIOLO, BRUNO, FELLI, LAMBERTO, STRAUB RH   +9 more
openaire   +3 more sources